Participant guide
How studies are reviewed and monitored
Before a CNS study you are considering can enroll a single person, an independent committee has to review it. That review does not end once the study begins.
Updated
Independent review
Before any CNS study you are considering can begin, its study plan and consent document are checked by an Institutional Review Board, known as an IRB. This board is a committee that operates separately from the researchers, so the people running the study are not the ones reviewing it. The checks do not stop at the start. They continue for as long as the study runs, and their purpose is to protect your rights and welfare as someone taking part.
Who runs CNS studies
As of November 16, 2026, 1,453 CNS studies are recruiting participants in the United States, according to ClinicalTrials.gov. By sponsor: university, hospital or other (1,106), industry (262), government (85). The sponsor is the organization responsible for a study.
Federal rules
In the United States, the rules for research come from federal regulations. Those rules spell out what you have to be told when you take part in a CNS study and which protections apply to you. The U.S. Food and Drug Administration adds its own oversight whenever a study is testing a medication or a device.
Monitoring during the study
At scheduled visits, the study team checks on your health and writes down any problems you tell them about. A serious concern can lead to a study being changed, paused, or stopped.
Oversight reduces risk, but it does not eliminate it. Every study carries risks. The known ones are described in the consent document.
Talk with a study coordinator
To talk through CNS studies with a coordinator, call (888) 520-7418 or send the short form. You will hear which studies might be a match and what would happen next. Questions are just questions. Nothing you ask signs you up for anything.
Sources and further reading
- Institutional Review Boards (IRBs) and Protection of Human Subjects in Clinical Trials — U.S. Food and Drug Administration
- Regulations to Protect Research Participants — HHS Office for Human Research Protections
- 45 CFR 46 — Protection of Human Subjects — U.S. Department of Health and Human Services